Shares of Addus HomeCare Corporation (NASDAQ:ADUS – Get Free Report) have received a consensus recommendation of “Moderate Buy” from the ten ratings firms that are covering the stock, MarketBeat Ratings reports. One analyst has rated the stock with a sell rating, two have assigned a hold rating, six have assigned a buy rating and one has assigned a strong buy rating to the company. The average twelve-month target price among brokerages that have covered the stock in the last year is $131.00.
A number of equities analysts have issued reports on ADUS shares. Wall Street Zen cut Addus HomeCare from a “strong-buy” rating to a “buy” rating in a report on Saturday, March 21st. Weiss Ratings lowered shares of Addus HomeCare from a “hold (c)” rating to a “hold (c-)” rating in a research note on Friday, May 22nd. Barclays reduced their price target on shares of Addus HomeCare from $102.00 to $92.00 and set an “underweight” rating for the company in a report on Friday, May 15th. Stephens decreased their price target on shares of Addus HomeCare from $140.00 to $135.00 and set an “overweight” rating for the company in a research note on Wednesday, February 25th. Finally, KeyCorp reissued an “overweight” rating on shares of Addus HomeCare in a research report on Wednesday, February 25th.
Get Our Latest Stock Report on Addus HomeCare
Institutional Investors Weigh In On Addus HomeCare
Addus HomeCare Stock Performance
Shares of ADUS stock opened at $92.70 on Wednesday. The stock has a market capitalization of $1.73 billion, a PE ratio of 17.13, a PEG ratio of 1.24 and a beta of 0.89. The business’s 50 day simple moving average is $93.78 and its 200 day simple moving average is $103.64. The company has a debt-to-equity ratio of 0.08, a current ratio of 1.83 and a quick ratio of 1.83. Addus HomeCare has a one year low of $87.95 and a one year high of $124.43.
Addus HomeCare (NASDAQ:ADUS – Get Free Report) last posted its quarterly earnings data on Monday, May 4th. The company reported $1.62 EPS for the quarter, beating analysts’ consensus estimates of $1.52 by $0.10. Addus HomeCare had a net margin of 6.89% and a return on equity of 9.80%. The company had revenue of $363.50 million for the quarter, compared to analyst estimates of $366.41 million. During the same period in the prior year, the firm posted $1.42 EPS. The company’s quarterly revenue was up 7.7% on a year-over-year basis. As a group, research analysts forecast that Addus HomeCare will post 6.24 earnings per share for the current year.
About Addus HomeCare
Addus HomeCare (NASDAQ: ADUS) is a leading provider of home and community-based care services for elderly, disabled, and medically complex individuals across the United States. Through a network of company-owned and franchise locations, the company delivers a broad spectrum of non-medical personal care and licensed home health services designed to support clients’ independence and quality of life.
The company’s core offerings include personal care assistance—covering daily living activities, medication reminders, and light housekeeping—and skilled home health services delivered under the supervision of registered nurses and licensed therapists.
Featured Articles
- Five stocks we like better than Addus HomeCare
- The Bank of Mom and Dad Is Booming—3 Stocks to Watch
- Corning Is Paving AI’s Future With Glass
- Why’s Amazon Suddenly Lagging the S&P 500, and Is It a Warning?
- Crypto Winter Is Here: 3 Stocks To Put On Ice This Summer
Receive News & Ratings for Addus HomeCare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Addus HomeCare and related companies with MarketBeat.com's FREE daily email newsletter.
